Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Molecular markers for granulovacuolar degeneration are present in rimmed vacuoles.

Nakamori M, Takahashi T, Nishikawa T, Yamazaki Y, Kurashige T, Maruyama H, Arihiro K, Matsumoto M.

PLoS One. 2013 Nov 28;8(11):e80995. doi: 10.1371/journal.pone.0080995. eCollection 2013.

2.

Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies.

Lagalwar S, Berry RW, Binder LI.

Acta Neuropathol. 2007 Jan;113(1):63-73. Epub 2006 Nov 7.

PMID:
17089132
3.

The origins of rimmed vacuoles and granulovacuolar degeneration bodies are associated with the Wnt signaling pathway.

Murata-Shinozaki Y, Takahashi T, Matsubara T, Maruyama H, Izumi Y, Matsumoto M.

Neurosci Lett. 2017 Jan 18;638:55-59. doi: 10.1016/j.neulet.2016.12.014. Epub 2016 Dec 7.

PMID:
27939356
4.

Phosphatidylinositol-4,5-bisphosphate is enriched in granulovacuolar degeneration bodies and neurofibrillary tangles.

Nishikawa T, Takahashi T, Nakamori M, Yamazaki Y, Kurashige T, Nagano Y, Nishida Y, Izumi Y, Matsumoto M.

Neuropathol Appl Neurobiol. 2014 Jun;40(4):489-501. doi: 10.1111/nan.12056.

5.

Cyclin-dependent kinase 5 immunoreactivity for granulovacuolar degeneration.

Nakamori M, Takahashi T, Yamazaki Y, Kurashige T, Yamawaki T, Matsumoto M.

Neuroreport. 2012 Oct 24;23(15):867-72. doi: 10.1097/WNR.0b013e328358720b.

PMID:
22968343
6.

Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus.

Yamazaki Y, Takahashi T, Hiji M, Kurashige T, Izumi Y, Yamawaki T, Matsumoto M.

Neurosci Lett. 2010 Jun 21;477(2):86-90. doi: 10.1016/j.neulet.2010.04.038. Epub 2010 Apr 24.

PMID:
20420883
7.

Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response.

Thal DR, Del Tredici K, Ludolph AC, Hoozemans JJ, Rozemuller AJ, Braak H, Knippschild U.

Acta Neuropathol. 2011 Nov;122(5):577-89. doi: 10.1007/s00401-011-0871-6. Epub 2011 Sep 21.

PMID:
21935637
8.

The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.

Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, Brion JP.

Acta Neuropathol. 2002 Feb;103(2):91-9. Epub 2001 Nov 29.

PMID:
11810173
9.

Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease.

Bondareff W, Wischik CM, Novak M, Roth M.

Am J Pathol. 1991 Sep;139(3):641-7.

11.

Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles.

Funk KE, Mrak RE, Kuret J.

Neuropathol Appl Neurobiol. 2011 Apr;37(3):295-306. doi: 10.1111/j.1365-2990.2010.01135.x.

12.

Localization of CHMP2B-immunoreactivity in the brainstem of Lewy body disease.

Kurashige T, Takahashi T, Yamazaki Y, Hiji M, Izumi Y, Yamawaki T, Matsumoto M.

Neuropathology. 2013 Jun;33(3):237-45. doi: 10.1111/j.1440-1789.2012.01346.x. Epub 2012 Sep 19.

PMID:
22989140
13.

Granulovacuolar degenerations appear in relation to hippocampal phosphorylated tau accumulation in various neurodegenerative disorders.

Yamazaki Y, Matsubara T, Takahashi T, Kurashige T, Dohi E, Hiji M, Nagano Y, Yamawaki T, Matsumoto M.

PLoS One. 2011;6(11):e26996. doi: 10.1371/journal.pone.0026996. Epub 2011 Nov 3.

14.

Increased expression of manganese superoxide dismutase is associated with that of nitrotyrosine in myopathies with rimmed vacuoles.

Tsuruta Y, Furuta A, Taniguchi N, Yamada T, Kira J, Iwaki T.

Acta Neuropathol. 2002 Jan;103(1):59-65.

PMID:
11837748
15.

Expression of the lysosome-associated membrane proteins in myopathies with rimmed vacuoles.

Tsuruta Y, Furuta A, Furuta K, Yamada T, Kira J, Iwaki T.

Acta Neuropathol. 2001 Jun;101(6):579-84.

PMID:
11515786
16.

Granulovacuolar degeneration and unfolded protein response in mouse models of tauopathy and Aβ amyloidosis.

Köhler C, Dinekov M, Götz J.

Neurobiol Dis. 2014 Nov;71:169-79. doi: 10.1016/j.nbd.2014.07.006. Epub 2014 Jul 27.

PMID:
25073087
17.

MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies.

Lund H, Gustafsson E, Svensson A, Nilsson M, Berg M, Sunnemark D, von Euler G.

Acta Neuropathol Commun. 2014 Feb 17;2:22. doi: 10.1186/2051-5960-2-22.

18.

Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology.

Köhler C.

Acta Neuropathol. 2016 Sep;132(3):339-59. doi: 10.1007/s00401-016-1562-0. Epub 2016 Apr 9. Review.

PMID:
27062260
19.

The identification of raft-derived tau-associated vesicles that are incorporated into immature tangles and paired helical filaments.

Nishikawa T, Takahashi T, Nakamori M, Hosomi N, Maruyama H, Miyazaki Y, Izumi Y, Matsumoto M.

Neuropathol Appl Neurobiol. 2016 Dec;42(7):639-653. doi: 10.1111/nan.12288. Epub 2015 Dec 2.

PMID:
26501932
20.

Oxidative stress and predominant Abeta42(43) deposition in myopathies with rimmed vacuoles.

Tateyama M, Takeda A, Onodera Y, Matsuzaki M, Hasegawa T, Nunomura A, Hirai K, Perry G, Smith MA, Itoyama Y.

Acta Neuropathol. 2003 Jun;105(6):581-5. Epub 2003 Mar 5.

PMID:
12734664

Supplemental Content

Support Center